policy
WVA position statement on use of horses for production of biologics and therapeutics
The AVMA endorses this position statement developed by the World Veterinary Association (WVA) on the use of horses for production of biologics and…
policy
Withdrawal of FDA approval for animal drug products
Loss of an animal drug product can have adverse effects on animal health, animal welfare and food safety.
policy
Veterinary foresight and expertise in antimicrobial discussions
Veterinarians are the professionals responsible for medical decisions, antimicrobial stewardship, and conscientious oversight of antimicrobial use in…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…
policy
Vaccination principles
Vaccines have been proven highly efficacious and beneficial to the health of veterinary patients, as well as the general public. Decisions about…
policy
Use of technology in veterinary medicine
The AVMA supports responsible and ethical development and use of technology that can benefit and protect public health, animal health and welfare, and…
policy
UNDER REVIEWUse of aquatic animal therapeutic agents
The AVMA recognizes the need for sufficient approved therapeutics to facilitate safe and effective prevention, diagnosis, treatment and control of…
policy
Use of prescription drugs in veterinary medicine
Veterinary prescription drugs are those drugs restricted by federal law to use by or on the order of a licensed veterinarian.
policy
Unapproved new animal drugs marketed as devices
The AVMA encourages increased enforcement in regulating the marketing of products represented as devices but appearing to be unapproved new animal…
policy
Therapeutic medications in racehorses
Health care decisions for individual horses are the responsibility of the veterinarian, trainer, and owner and must have the best interests of the…
policy
Therapeutic medications in competition equids
The AVMA condemns the administration of non-therapeutic or unprescribed medications to competition equids. Health care decisions regarding individual…
policy
The veterinary profession's role in addressing the opioid epidemic
AVMA strongly recommends that veterinarians, legislators, state veterinary medical boards, and state pharmacy boards work together to create practical…
policy
Support for the collection of antimicrobial use data for antimicrobial stewardship
Antimicrobials are necessary tools for protecting animal health and wellbeing. Antimicrobial stewardship is successful only when all partners involved…
policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
policy
Safety testing
The AVMA supports research to discover and develop safe and efficacious drugs, vaccines, biologicals, and medical devices that benefit animals and…
policy
Restriction of veterinary biologics to veterinarians' use
The AVMA supports USDA efforts to restrict all veterinary biologics used in disease control programs, those with high incidence of reactions, and…
policy
Representation to the United States Pharmacopeial Convention (USP)
The AVMA encourages expansion of veterinary membership to the USP, such as representation of veterinary pharmacologists.
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Rabies
Rabies is almost invariably fatal for animals and humans. Vaccination of animals is a critical step in preventing infection and protecting public…
policy
Notification to the veterinarian of violative residues in foods of animal origin
Veterinarians have an essential role in preventing such violations and ensuring the appropriate and judicious use of pharmaceuticals on food animal…
policy
National Antimicrobial Resistance Monitoring System (NARMS)
The AVMA recognizes the National Antimicrobial Resistance Monitoring System (NARMS) as a resource for information on antimicrobial resistance trends…
policy
Limited prohibition on extralabel drug use
Any regulatory prohibition of extralabel drug use in animals should be science-based and as limited in scope as possible, consistent with protecting…
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials in aquatic animal medicine
Aquatic animal veterinarians should use all therapeutants, including antimicrobials, judiciously to restore aquatic animal health, ensure continued…
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials
Judicious therapeutic use of antimicrobials is a core principle of the broader goal of antimicrobial stewardship.
policy
Joint AVMA-FVE-CVMA statement on responsible and judicious use of antimicrobials
The AVMA, Federation of Veterinarians of Europe, and Canadian Veterinary Medical Association have jointly adopted this policy on responsible and…